Feline intestinal mast cell tumours: clinicopathological characterisation and KIT mutation analysis

ObjectivesFeline intestinal mast cell tumours (FIMCTs) are rare and reportedly characterised by poor differentiation, aggressive biological behaviour and lack of reliable therapeutic aids. KIT proto-oncogene-activating mutations have never been …